Skip to main content
Premium Trial:

Request an Annual Quote

Sneak a Peek at Pfizer's Compounds

Pfizer is letting people screen its proprietary compounds, says Derek Lowe at In the Pipeline. "As I understand it, you need to come to them with a reasonably formatted HTS assay, and there's a fee in the high hundreds of thousands to run the screen," Lowe writes, and that set-up doesn't strike him as "much of a moneymaker." Instead, he says it's probably a way for Pfizer to make deals with smaller companies since the compounds are likely covered by Pfizer patents.

The Scan

Boosters Chasing Variants

The New York Times reports that an FDA advisory panel is to weigh updated booster vaccines for COVID-19.

Not Yet

The World Health Organization says monkeypox is not yet a global emergency, the Washington Post reports.

More Proposed for Federal Research

Science reports that US House of Representatives panels are seeking to increase federal research funding.

PLOS Papers on Breast Cancer Metastasis, Left-Sided Cardiac Defects, SARS-CoV-2 Monitoring

In PLOS this week: link between breast cancer metastasis and CLIC4, sequencing analysis of left-sided cardiac defects, and more.